We're designing a new online promotional campaign for 'Face the Sun,' and are in need of some short, personal videos discussing how cancer has impacted individuals and families.
Here's what we're looking for; the videos can be done on laptops webcams, would be 1-3 minutes in length, and would roughly follow the pattern, 'Hi I'm... from... and this is how cancer has affected my life.' If the person doing the video is a family member who's lost someone, then it would be awesome if at some point they could show the camera a picture of who it is they have lost. We'll post the videos to a special youtube channel we've created, and then edit them down into a series of online awareness ads.
We don't want to generate work for organizations who are already too often short-handed, but some of your organizations have already compiled similar stories, and perhaps some of those people might be willing to share their stories again, in this way.
If you have any questions about this project, or about 'Face the Sun' generally, please don't hesitate to contact me. Together we're making a difference.
Mike Moroz, writer/producer
[email protected]>
Sunflower Pictures
http://www.facethesunmovie.com
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...